Novartis Investigative Site — Charlotte, North Carolina

Novartis Investigative Site is a clinical research site located in Charlotte, North Carolina, United States 28211.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 70 clinical trials with 1 currently active.

Therapeutic areas: Major Depressive Disorder, Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis.

Sponsors: Novartis, Novartis Pharmaceuticals, Debiopharm International SA.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 70 clinical trials on record, with 1 currently active. Their work covers Major Depressive Disorder, Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis.

Is Novartis Investigative Site accredited by Crixeo Health?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.